Lifting of Suspension

At Trading Venue FNSE

Issuer: Xbrane Biopharma AB, LEI: 5493008DKD05APTKQO39
Instrument: XBRANE, ISIN SE0007789409
Lifting reason: With reference to the press release published by Xbrane Biopharma AB on July 12, 2018 at 17:00 CET
Continuous trading from: July 13, 2018, with normal opening procedure
Comments: Order books have been flushed
Related instruments: N/A
Contact details: Issuer Surveillance +46 8 405 60 00 Trading Surveillance +46 8 405 60 00

The Financial Supervisory Authority for FNSE has been notified

Nasdaq Stockholm AB